abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Financing Cash Flow
-$16.60M
Quarterly · Period ending: · USD
HQL Financing Cash Flow
Latest reported-$16.60Mperiod ending
Latest reported-$16.60Mperiod ending
HQL Quarterly Cash from Financing ($0.00 → -$16.60M)
Quarterly financing cash flow
High-resolution chart · PNG
HQL financing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| -16,595,282 | |
| -23,218,506 | |
| -8,414,500 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 10,067 | |
| -10,067 | |
| 58,614 | |
| -6,084 | |
| -5,036 | |
| -2,200 | |
| -4,111,264 | |
| -16,993,718 | |
| -59,150,000 | |
| -59,150,000 | |
| -3,650,000 | |
| -3,650,000 | |
| -3,800,000 | |
| -3,800,000 | |
| -5,900,000 | |
| -5,900,000 | |
| -5,300,000 | |
| -5,300,000 | |
| 30,150,000 | |
| 30,150,000 | |
| -3,650,000 | |
| -3,650,000 | |
| -2,850,000 | |
| -2,850,000 | |
| -2,950,000 | |
| -2,950,000 | |
| -3,600,000 | |
| -3,600,000 | |
| -4,050,000 | |
| -4,050,000 | |
| -1,580,000 | |
| -20,000 | |
| -3,150,000 | |
| -3,150,000 | |
| 0 | |
| 0 |